Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 220

1.

Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge.

Genescà M, Ma ZM, Wang Y, Assaf B, Qureshi H, Fritts L, Huang Y, McChesney MB, Miller CJ.

J Virol. 2012 Sep;86(17):9188-200. doi: 10.1128/JVI.00532-12. Epub 2012 Jun 13.

PMID:
22696662
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Antiviral CD8+ T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6.

Genescà M, McChesney MB, Miller CJ.

J Intern Med. 2009 Jan;265(1):67-77. doi: 10.1111/j.1365-2796.2008.02051.x. Review.

PMID:
19093961
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

With minimal systemic T-cell expansion, CD8+ T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus.

Genescà M, Skinner PJ, Hong JJ, Li J, Lu D, McChesney MB, Miller CJ.

J Virol. 2008 Nov;82(22):11181-96. doi: 10.1128/JVI.01433-08. Epub 2008 Sep 10.

PMID:
18787003
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys.

Genescà M, Skinner PJ, Bost KM, Lu D, Wang Y, Rourke TL, Haase AT, McChesney MB, Miller CJ.

Mucosal Immunol. 2008 May;1(3):219-28. doi: 10.1038/mi.2008.6. Epub 2008 Mar 5.

PMID:
19079181
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Limited dissemination of pathogenic SIV after vaginal challenge of rhesus monkeys immunized with a live, attenuated lentivirus.

Stone M, Ma ZM, Genescà M, Fritts L, Blozois S, McChesney MB, Miller CJ.

Virology. 2009 Sep 30;392(2):260-70. doi: 10.1016/j.virol.2009.06.052. Epub 2009 Aug 3.

PMID:
19647847
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.

Qureshi H, Ma ZM, Huang Y, Hodge G, Thomas MA, DiPasquale J, DeSilva V, Fritts L, Bett AJ, Casimiro DR, Shiver JW, Robert-Guroff M, Robertson MN, McChesney MB, Gilbert PB, Miller CJ.

J Virol. 2012 Feb;86(4):2239-50. doi: 10.1128/JVI.06175-11. Epub 2011 Dec 7.

PMID:
22156519
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.

Stevceva L, Alvarez X, Lackner AA, Tryniszewska E, Kelsall B, Nacsa J, Tartaglia J, Strober W, Franchini G.

J Virol. 2002 Nov;76(22):11659-76.

PMID:
12388726
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.

Enose Y, Kita M, Yamamoto T, Suzuki H, Miyake A, Horiuchi R, Ibuki K, Kaneyasu K, Kuwata T, Takahashi E, Sakai K, Shinohara K, Miura T, Hayami M.

Arch Virol. 2004 Sep;149(9):1705-20.

PMID:
15593414
[PubMed - indexed for MEDLINE]
11.

Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine.

Sparger EE, Dubie RA, Shacklett BL, Cole KS, Chang WL, Luciw PA.

Virology. 2008 May 10;374(2):261-72. doi: 10.1016/j.virol.2008.01.020. Epub 2008 Feb 7.

PMID:
18261756
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.

Abel K, Rourke T, Lu D, Bost K, McChesney MB, Miller CJ.

J Infect Dis. 2004 Nov 1;190(9):1697-705. Epub 2004 Sep 24. Erratum in: J Infect Dis. 2005 Mar 15;191(6):1028.

PMID:
15478078
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.

Kumar A, Mukherjee S, Shen J, Buch S, Li Z, Adany I, Liu Z, Zhuge W, Piatak M Jr, Lifson J, McClure H, Narayan O.

Virology. 2002 Sep 30;301(2):189-205.

PMID:
12359422
[PubMed - indexed for MEDLINE]
Free Article
14.

Emergence of simian immunodeficiency virus-specific cytotoxic CD4+ T cells and increased humoral responses correlate with control of rebounding viremia in CD8-depleted macaques infected with Rev-independent live-attenuated simian immunodeficiency virus.

von Gegerfelt A, Valentin A, Alicea C, Van Rompay KK, Marthas ML, Montefiori DC, Pavlakis GN, Felber BK.

J Immunol. 2010 Sep 15;185(6):3348-58. doi: 10.4049/jimmunol.1000572. Epub 2010 Aug 11.

PMID:
20702730
[PubMed - indexed for MEDLINE]
Free Article
15.

Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.

Engram JC, Dunham RM, Makedonas G, Vanderford TH, Sumpter B, Klatt NR, Ratcliffe SJ, Garg S, Paiardini M, McQuoid M, Altman JD, Staprans SI, Betts MR, Garber DA, Feinberg MB, Silvestri G.

J Immunol. 2009 Jul 1;183(1):706-17. doi: 10.4049/jimmunol.0803746.

PMID:
19542473
[PubMed - indexed for MEDLINE]
Free Article
16.

Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.

Tsukamoto T, Yuasa M, Yamamoto H, Kawada M, Takeda A, Igarashi H, Matano T.

J Virol. 2007 Nov;81(21):11640-9. Epub 2007 Aug 29.

PMID:
17728225
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.

Miyake A, Akagi T, Enose Y, Ueno M, Kawamura M, Horiuchi R, Hiraishi K, Adachi M, Serizawa T, Narayan O, Akashi M, Baba M, Hayami M.

J Med Virol. 2004 Jul;73(3):368-77.

PMID:
15170630
[PubMed - indexed for MEDLINE]
18.

A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease.

Amara RR, Patel K, Niedziela G, Nigam P, Sharma S, Staprans SI, Montefiori DC, Chenareddi L, Herndon JG, Robinson HL, McClure HM, Novembre FJ.

J Virol. 2005 Dec;79(24):15356-67.

PMID:
16306607
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge.

Doria-Rose NA, Ohlen C, Polacino P, Pierce CC, Hensel MT, Kuller L, Mulvania T, Anderson D, Greenberg PD, Hu SL, Haigwood NL.

J Virol. 2003 Nov;77(21):11563-77.

PMID:
14557642
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.

Lü X, Kiyono H, Lu D, Kawabata S, Torten J, Srinivasan S, Dailey PJ, McGhee JR, Lehner T, Miller CJ.

AIDS. 1998 Jan 1;12(1):1-10.

PMID:
9456249
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk